Discontinued — last reported Q4 '24
Illumina San Diego, California — Right-of-use asset impairment remained flat by 0.0% to $4.75M in Q4 2024 compared to the prior quarter. Year-over-year, this metric declined by 9.5%, from $5.25M to $4.75M. This is a positive signal — lower values indicate better performance for this metric.
An increase suggests underutilization of facilities or a strategic contraction of the company's footprint in the region, while a decrease indicates stable or optimized real estate usage.
This metric represents the non-cash charge recognized when the carrying amount of right-of-use assets associated with op...
Peers in the life sciences sector often report similar lease impairments when consolidating R&D or manufacturing hubs, typically benchmarked against total regional lease liabilities.
ilmn_segment_san_diego_california_right_of_use_asset_impairment| FY'23 | FY'24 | |
|---|---|---|
| Value | $21.00M | $19.00M |
| YoY Change | — | -9.5% |